Cargando…
SUN-128 Impaired Fasting Glucose Is Associated with Insulin Resistance in Patients with Germline Mutations in the Multiple Endocrine Neoplasia Type 1 (MEN1) Gene
BACKGROUND: Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant syndrome characterized by hyperparathyroidism, pituitary adenomas, and gastro-entero-pancreatic neuroendocrine tumors. Patients with MEN1 mutations have impaired glucose homeostasis, but the role of insulin resistance an...
Autores principales: | Bansal, Rashika, Armiyaw, Latif, Lee, Maya, Tepede, Aisha, James, Welch, Agarwal, Sunita Kishore, Simonds, William F, Weinstein, Lee Scott, Muniyappa, Ranganath, Blau, Jenny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209696/ http://dx.doi.org/10.1210/jendso/bvaa046.1735 |
Ejemplares similares
-
SUN-116 The Role of (68)Gallium DOTATATE PET/CT Versus (18)F-FDOPA PET/CT in the Imaging of Neuroendocrine Neoplasms in Patients with Multiple Endocrine Neoplasia Type 1 (MEN1)
por: Tepede, Aisha, et al.
Publicado: (2020) -
SUN-124 Are Venous Thromboembolic Events Increased in MEN1 Patients?
por: Lee, Maya E, et al.
Publicado: (2020) -
MON-321 Metastatic Melanoma with Unknown Primary Site in a Patient with Multiple Endocrine Neoplasia Type 1
por: Kamilaris, Crystal, et al.
Publicado: (2019) -
MON-LB055 A Single Center Experience of Multiple Endocrine Neoplasia Type 1 (MEN1) vs Sporadic Insulinoma: What Can We Learn and Where Are We Going?
por: Itatani, Miho, et al.
Publicado: (2019) -
Thymoma and Not Just Thymic Carcinoid Can Be Associated With Multiple Endocrine Neoplasia Type 1
por: Graf, Akua, et al.
Publicado: (2021)